| Literature DB >> 15526073 |
Abstract
Topics of this survey are the indications and use of plasma-derived and recombinant coagulation factor concentrates. These substitution therapies need to be handled carefully by weighing up their effectiveness against the long and short term side effects in the individual patient.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15526073 DOI： 10.1267/hämo04040286
Source DB: PubMed Journal: Hamostaseologie ISSN： 0720-9355 Impact factor: 1.778